Stocks Comparison
Edwards Lifesciences vs STERIS: revenue, profit, margins and growth compared
Edwards Lifesciences brought in $6.1B of revenue in fiscal 2025, STERIS $5.9B in fiscal 2026. Revenue changed by +11.5% at Edwards Lifesciences and +8.7% at STERIS on the year before, so Edwards Lifesciences grew faster. Edwards Lifesciences kept 17.7% of its revenue as net profit, STERIS 13.2%. Free cash flow was $1.3B at Edwards Lifesciences and $972.4M at STERIS.
Side by side, latest fiscal year
| EW | STE | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2026 (March 31, 2026) |
| Revenue | $6.1B | $5.9B |
| Revenue growth | +11.5% | +8.7% |
| Net income | $1.1B | $782.3M |
| Net margin | 17.7% | 13.2% |
| Free cash flow | $1.3B | $972.4M |
| Free cash flow margin | 22.0% | 16.4% |
| Earnings per share (diluted) | $1.83 | $7.93 |
| Cash | $2.9B | $439.6M |
| Debt | $598.3M | $1.8B |
| Price to earnings | 47.1 | 26.4 |
| Market value | $49.7B | $20.4B |
| Dividend yield | n/a | 1.18% |
| Rank by revenue in sector | #54 of 523 · Health care | #55 of 523 · Health care |
Over the years
Questions about Edwards Lifesciences and STERIS
Which is bigger by revenue, Edwards Lifesciences or STERIS?
Edwards Lifesciences is bigger by revenue: $6.1B in fiscal 2025, against $5.9B for STERIS in fiscal 2026.
Which keeps more of its revenue as profit, Edwards Lifesciences or STERIS?
Edwards Lifesciences had a net margin of 17.7% in fiscal 2025; STERIS had 13.2% in fiscal 2026.
Which grew revenue faster, Edwards Lifesciences or STERIS?
In their latest fiscal years revenue changed by +11.5% at Edwards Lifesciences and +8.7% at STERIS.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.